At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BBH VanEck Biotech ETF
Post-Mkt 08-28 19:22:50 EDT
236.48
-5.51
-2.28%
盘后236.48
+0.000.00%
16:10 EDT
High239.92Low235.99Vol11.60K
Open239.92D1 Closing241.99Amplitude1.63%
Mkt Cap467.40MTradable Cap467.40MTotal Shares1.98M
T/O2.75MT/O Rate0.59%Tradable Shares1.98M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Crinetics Shareholders Approve Vertex Acquisition at Special Meeting
TIPRANKS  ·  05:33
Crinetics Shareholders Approve Vertex Acquisition at Special Meeting
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  04:35
Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors
Amgen Inc. Stock Underperforms Friday When Compared to Competitors
Dow Jones  ·  04:34
Amgen Inc. Stock Underperforms Friday When Compared to Competitors
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
TIPRANKS  ·  01:20
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
TIPRANKS  ·  00:30
Vertex Tests VX-407’s Impact on Birth Control: What It Means for VRTX Investors
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
TIPRANKS  ·  00:30
Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors
Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says
MT Newswires Live  ·  00:18
Revolution Medicines Set to Post 'Strong Launch' for Rasonque, UBS Says
Political and General News Events from August 28
Reuters  ·  08-28 20:30
Political and General News Events from August 28
US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech
Deep News  ·  08-28 18:24
US Regulator Approves Novel Pancreatic Cancer Therapy, Marking Major Win for Independent Biotech
Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push
Reuters  ·  08-28 10:17
Gilead Breaks Ground on Foster City Biologics Facility in $32 Billion US Investment Push
Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent
Dow Jones  ·  08-28 09:21
Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent
Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares
Reuters  ·  08-28 06:45
Gilead Sciences Director Anthony Welters Disposes of USD 2.64 Million in Common Shares
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
TIPRANKS  ·  08-28 05:55
Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV
US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment
Reuters  ·  08-28 05:50
US FDA Approves Gilead's Once-Daily Combination Pill for HIV Treatment
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens
THOMSON REUTERS  ·  08-28 05:47
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults with Hiv, Including Those on Complex Regimens
Moderna Inc. Stock Slips 4.6%, Underperforms Peers
Dow Jones  ·  08-28 04:34
Moderna Inc. Stock Slips 4.6%, Underperforms Peers
Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
TIPRANKS  ·  08-28 00:31
Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets
Revolution Medicines' Rasonque Label Expands Commercial Opportunity, Oppenheimer Says
MT Newswires Live  ·  08-28 00:21
Revolution Medicines' Rasonque Label Expands Commercial Opportunity, Oppenheimer Says
Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)
TIPRANKS  ·  08-27 23:20
Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)
HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million
Reuters  ·  08-27 22:01
HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Introduction

Company Name.
VanEck Biotech ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Issue price:
--